BIRADS classifications
BIRAD 0-
Incomplete.
Needs additional imaging evaluation, recommend ________.
BIRAD 1-
Negative.
Recommend annual screening mammograms.
BIRAD 2-
Benign findings.
Recommend annual screening mammograms.
BIRAD 3-
Probably benign findings (less than 2% chance of malignancy).
Short interval follow up is suggested.
Recommend ________ (6 month f/u diagnostic mammogram/ US/ etc).
BIRAD 4A-
Low suspicion abnormality (2-10% chance of malignancy).
Recommend ________ (Stereotactic/ ultrasound guided/ etc) biopsy.
BIRAD 4B-
Intermediate suspicion abnormality (10-50% chance of malignancy).
Recommend ________ (Stereotactic/ ultrasound guided/ etc) biopsy.
BIRAD 4C-
Moderate suspicion abnormality (50-95% chance of malignancy).
Recommend ________ (Stereotactic/ ultrasound guided/ etc) biopsy.
BIRAD 5-
Highly suggestive of malignancy (greater than 95% chance of malignancy).
Appropriate action should be taken.
Recommend ________. (Surgical consultation)
BIRAD 6-
Known and biopsy proven malignancy.
Incomplete.
Needs additional imaging evaluation, recommend ________.
BIRAD 1-
Negative.
Recommend annual screening mammograms.
BIRAD 2-
Benign findings.
Recommend annual screening mammograms.
BIRAD 3-
Probably benign findings (less than 2% chance of malignancy).
Short interval follow up is suggested.
Recommend ________ (6 month f/u diagnostic mammogram/ US/ etc).
BIRAD 4A-
Low suspicion abnormality (2-10% chance of malignancy).
Recommend ________ (Stereotactic/ ultrasound guided/ etc) biopsy.
BIRAD 4B-
Intermediate suspicion abnormality (10-50% chance of malignancy).
Recommend ________ (Stereotactic/ ultrasound guided/ etc) biopsy.
BIRAD 4C-
Moderate suspicion abnormality (50-95% chance of malignancy).
Recommend ________ (Stereotactic/ ultrasound guided/ etc) biopsy.
BIRAD 5-
Highly suggestive of malignancy (greater than 95% chance of malignancy).
Appropriate action should be taken.
Recommend ________. (Surgical consultation)
BIRAD 6-
Known and biopsy proven malignancy.